The FDA pushed back its decision date on Cytokinetics heart drug, while AstraZeneca got Phase 3 trial results that could help ...

Have you ever wondered about what became of COVID vaccine companies after the pandemic settled down? Find out in this article ...

The team at GSK are still in the discovery phase, meaning they are yet to select a candidate vaccine that can be taken ...

The U.S. Food and Drug Administration (FDA) is planning to require all new vaccines to undergo placebo-controlled trials ...

The Trump administration is investing $500M in a project to develop "universal" vaccines that protect against multiple virus ...

Explore the latest NSCLC new treatments in development, including candidates aimed at tackling hard-to-treat, late-stage lung ...

The FDA approved AstraZeneca's Truqap in November 2023 for the treatment of advanced HR-positive breast cancer.

It’s an incredibly exciting time for AstraZeneca in Canada,” says Gaby Bourbara, President, AstraZeneca Canada. “Since 2023, we have invested $4.3 billion in Canada’s l ...

Analysis found 25% tariff on pharmaceutical imports would hike U.S. drug costs by nearly $51 billion annually, boosting ...

Jenny Strasburg is a reporter in London, where she writes for The Wall Street Journal about oil and gas, climate, the ...

Bojan Pancevski is The Wall Street Journal’s chief European political correspondent, covering European and global affairs. He ...

AstraZeneca Chief Executive Officer Pascal Soriot said on Wednesday that just like Europe has stepped up its defence spending ...